Faculty

Institution

Unit

Venue

Elizabeth M. Gore, MD, FACR

Professor of Radiation Oncology; Section Chief Radiation Oncology Milwaukee VA Medical Center

Medical College of Wisconsin

Affiliations

Department of Medicine

Radiation Oncology

Elizabeth M. Gore, Md, Facr is currently serving as a Medicine Professor of Radiation Oncology; Section Chief Radiation Oncology Milwaukee VA Medical Center at Medical College of Wisconsin.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Elizabeth M. Gore, MD, FACR

Medical College of Wisconsin

Professor of Radiation Oncology; Section Chief Radiation Oncology Milwaukee VA Medical Center

You can click a keyword to filter the displayed items

radiation oncology oncology lung cancer radiation therapy thoracic oncology radiation radiology cancer research medicine cancer treatment clinical radiation oncology cancer care radiation biology cancer imaging prostate cancer urology medical imaging medical physics clinical trials surgical oncology cancer management esophageal cancer radiation therapy planning clinical research respiratory medicine computed tomography prophylactic cranial irradiation elderly patients biomedical imaging cancer biology jama oncology medicinal research thoracic surgery magnetic resonance imaging secondary analysis brain metastases neuroradiology brachytherapy concurrent chemotherapy phase iii trial non-small-cell lung cancer neoadjuvant therapy brain tumor research oncogenes cancer discovery benchmark studies prognostic biomarkers medical image analysis cancer genomics respiration (physiology) intermediate-risk prostate cancer rtog studies radiation pneumonitis overall survival prostate cancer patients neurointerventional surgery cancer cells therapeutic efficacy comorbidity disease progression exercise science tumor targeting epigenomics primary analysis localized prostate cancer cardiovascular mortality sensor applications selective separation motion capture pulmonary circulation key site primary investigation geriatric medicine clinical gerontology small cell combined modality treatment pathology

Notable Scholarly Works

Notable Federal Grants

Collaborators

5-Hydroxymethylcytosine Sequencing of Plasma Cell-Free Dna Identifies Epigenomic Features in Prostate Cancer Patients Receiving Androgen Deprivation Therapies. Communications Medicine (2025)

Qianxia LiChiang-Ching HuangShane HuangYijun TianJinyong HuangAmirreza BitarafXiaowei DongMarja T. NevalainenManishkumar PatelJodie WongJingsong ZhangBrandon J. ManleyJong Y. ParkManish KohliElizabeth M. GoreDeepak KilariLiang Wang

medicineepigenomicsprostate cancerandrogen deprivation therapiesprostate cancer patients

Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III Trials. Journal of Clinical Oncology (2025)

Andrew J. ArmstrongVinnie Y.T. LiuRamprasaath R. SelvarajuEmmalyn ChenJeffry P. SimkoSandy DeVriesOliver SartorHoward M. SandlerOsama MohamadHuei-Chung HuangJacqueline GriffinRikiya YamashitaAndre EstevaPhuoc T. TranDaniel E. SprattJohn Hi CarsonChristopher PetersElizabeth GoreSteve P. LeeJedidiah M. MonsonMark E. AugspurgerAli El-GayedJoseph P. RodgersRana McKayTodd MorganFelix Y. FengPaul L. Nguyen

biomarkersbiomedical informaticsurologyoncologycancer researchartificial intelligenceclinical proteomicscancer discoveryradiation oncologysurgical oncologyprostatic diseasecancer imagingclinical radiation oncologybiomarker (medicine)high-risk prostate cancerprostate cancerprognostic biomarkerslong-term hormonal therapydigital pathologypathology

Evaluation of Post Radiotherapy Psa as a Prognostic and Predictive Biomarker in High Risk Prostate Cancer: A Secondary Analysis of Rtog 0521.. Journal of Clinical Oncology (2025)

Paul KofferChristina RakerThomas A. DiPetrilloBenedito A. CarneiroAnthony E. MegaHoward M. SandlerGeorge B RodriguesAmit B ShahJason A. EfstathiouSusan ChafeAlexander G. BaloghScott G WilliamsDeborah A. KubanElizabeth GoreJessica Karen WongMarie DuclosPaul L. NguyenFelix Y Feng

radiation therapybiomarkersurologyoncologycancer researchprognosiscancer carecancer discoveryradiation oncologyradiologysurvival analysispredictive biomarkersurgical oncologycancer imagingprognostic evaluationpost radiotherapy psaclinical radiation oncologythoracic oncologysecondary analysisprostate cancerprognostic biomarkers

Portos Gene Signature as a Predictor of Risk of Adverse Events After Dose-Escalated vs. Lower-Dose Prostate Radiation Therapy in Nrg/Rtog 0126.. Journal of Clinical Oncology (2025)

Karen E. HoffmanSophia C. KamranHyunnam Monica RyuJames A. ProudfootElai DavicioniPaul L. NguyenStephanie L. PughDaniel Eidelberg SprattJeff M. MichalskiMatthew ParliamentIan S. DayesRohann CorreaJohn M RobertsonElizabeth GoreDesiree E. DoncalsEric VigneaultLuis SouhamiFelix Y FengPhuoc T. TranShuang Zhao

radiation biologyradiation safetypatient safetyadverse eventsurologyoncologycancer researchcancer carecancer riskportos gene signatureradiation oncologyvascular biologyradiologynuclear medicinesurgical oncologycancer imagingclinical radiation oncologyprostate cancerclinical research

Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (Nrg/Rtog 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy. The Prostate (2025)

urologysurgical oncologyprostatic diseaseradiation therapyoncologyradiation oncologylymph node yieldcancer careclinical radiation oncologysalvage radiationprostate cancerprostate cancer patients

Radiobiologically Equivalent Deformable Dose Mapping for Re-Irradiation Planning: Implementation, Robustness, and Dosimetric Benefits. Radiotherapy and Oncology (2025)

Juan A García-AlvarezEric PaulsonKristofer KainzLindsay PuckettMonica E ShuklaFan ZhuElizabeth GoreAn Tai

re-irradiation planningradiation therapydosimetric benefitsoncologyradiation oncologyradiationclinical radiation oncologyequivalent deformable doseradiologyradiation therapy planningdosimetry

Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of Nrg/Rtog 9202. European Urology Focus (2024)

Kimberley S. MakMolly Scannell BryanJames J. DignamWilliam U. ShipleyYue LinChristopher A. PetersElizabeth M. GoreSeth A. RosenthalKenneth L. ZeitzerDavid P. D'SouzaEric M. HorwitzThomas M. PisanskyJordan M. MaierSusan M. ChafeTyler P. RobinMack RoachPhuoc T. TranLuis SouhamiJeff M. MichalskiAlan C. HartfordFelix Y. FengHoward M. SandlerJason A. Efstathiou

urologycardiovascular mortalityandrogen deprivationlong-term updateprostate canceradvanced prostate cancer

Mri for the Assessment of Pre-Treatment Regional Cardiac Dysfunction in Thoracic Cancer Patients. Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition (2024)

El-Sayed IbrahimAntonio SosaJadranka StojanovskaLindsay PuckettElizabeth GoreCarmen Bergom

magnetic resonance imagingmedicinemagnetic resonancethoracic cancer patientsmedical imaging

Patient-Reported Outcomes (Pros) in Nrg Oncology Rtog 0436: A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Esophageal Cancer Treated Without Surgery. Quality of Life Research (2024)

Lisa A. KachnicKathryn WinterMohan SuntharalingamDavid IlsonAndré KonskiShane LloydSarah A. McAvoyThomas LadOlugbenga Gbenga OlowokurePamela SamsonElizabeth M. GoreJoshua E. MeyerGregory M. M. VideticDavid A. ClumpAdam RabenOmar KayalehJerry BarkerMichael G. HaddockJudith O. HopkinsDeborah W. Bruner

radiation therapyurologyphase iii trialoncologycancer researchesophageal cancercancer carecancer treatmentclinical trialsradiation oncologyradiologyjama oncologyquality of lifesurgical oncologycancer imagingcancer managementthoracic oncologyoutcomes researchpatient-reported outcomes

5-Hydroxymethylcytosine Sequencing in Plasma Cell-Free Dna Identifies Unique Epigenomic Features in Prostate Cancer Patients Resistant to Androgen Deprivation Therapy. medRxiv (Cold Spring Harbor Laboratory) (2023)

Qianxia LiChiang-Ching HuangShane HuangYijun TianJinyong HuangAmirreza BitarafXiaowei DongMarja T. NevalanenManishkumar PatelJodie WongJingsong ZhangBrandon J. ManleyJong Y. ParkManish KohliElizabeth M. GoreDeepak KilariLiang Wang

urologycancer genomicsmedicineoncologycancer researchgenomicspharmacologyepigenomicsprostate cancer

1
2
3
4
5
22
10 / page

Elizabeth M. Gore, MD, FACR

Professor of Radiation Oncology; Section Chief Radiation Oncology Milwaukee VA Medical Center

Medical College of Wisconsin

Affiliations

Department of Medicine

Radiation Oncology

Elizabeth M. Gore, Md, Facr is currently serving as a Medicine Professor of Radiation Oncology; Section Chief Radiation Oncology Milwaukee VA Medical Center at Medical College of Wisconsin.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Elizabeth M. Gore, MD, FACR

Medical College of Wisconsin

Professor of Radiation Oncology; Section Chief Radiation Oncology Milwaukee VA Medical Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

5-Hydroxymethylcytosine Sequencing of Plasma Cell-Free Dna Identifies Epigenomic Features in Prostate Cancer Patients Receiving Androgen Deprivation Therapies. Communications Medicine (2025)

medicineepigenomicsprostate cancerandrogen deprivation therapiesprostate cancer patients

Evaluation of Post Radiotherapy Psa as a Prognostic and Predictive Biomarker in High Risk Prostate Cancer: A Secondary Analysis of Rtog 0521.. Journal of Clinical Oncology (2025)

Portos Gene Signature as a Predictor of Risk of Adverse Events After Dose-Escalated vs. Lower-Dose Prostate Radiation Therapy in Nrg/Rtog 0126.. Journal of Clinical Oncology (2025)

Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (Nrg/Rtog 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy. The Prostate (2025)

urologysurgical oncologyprostatic diseaseradiation therapyoncologyradiation oncologylymph node yieldcancer careclinical radiation oncologysalvage radiationprostate cancerprostate cancer patients

Radiobiologically Equivalent Deformable Dose Mapping for Re-Irradiation Planning: Implementation, Robustness, and Dosimetric Benefits. Radiotherapy and Oncology (2025)

Juan A García-AlvarezEric PaulsonKristofer KainzLindsay PuckettMonica E ShuklaFan ZhuElizabeth GoreAn Tai

re-irradiation planningradiation therapydosimetric benefitsoncologyradiation oncologyradiationclinical radiation oncologyequivalent deformable doseradiologyradiation therapy planningdosimetry

Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of Nrg/Rtog 9202. European Urology Focus (2024)

urologycardiovascular mortalityandrogen deprivationlong-term updateprostate canceradvanced prostate cancer

El-Sayed IbrahimAntonio SosaJadranka StojanovskaLindsay PuckettElizabeth GoreCarmen Bergom

magnetic resonance imagingmedicinemagnetic resonancethoracic cancer patientsmedical imaging

urologycancer genomicsmedicineoncologycancer researchgenomicspharmacologyepigenomicsprostate cancer

1
2
3
4
5
22
10 / page

Similar Faculty Members

William A. Hall, MD

Institution

Medical College of Wisconsin

radiation oncology

cancer research

Christopher Kelsey

Institution

Duke University

brain tumor research

mesothelioma

Russell Hales

Institution

Johns Hopkins University

radiation oncology

oncology

Graham W. Warren, M.D., Ph.D

Institution

Medical University of South Carolina

oncology

cancer care

Timothy Showalter

Institution

University of Virginia

radiation oncology

oncology

Amar U. Kishan

Institution

University of California, Los Angeles

radiation oncology

clinical outcomes research

Maria Werner-Wasik

Institution

Thomas Jefferson University

clinical radiation oncology

radiation oncology

Matthew Schipper

Institution

University of Michigan

radiation oncology

oncology

Billy Loo

Institution

Stanford University

radiation oncology

oncology

Clifford G. Robinson

Institution

Washington University in St. Louis

radiation

radiation oncology

Similar Faculty Members

William A. Hall, MD

Institution

Medical College of Wisconsin

radiation oncology

cancer research

Christopher Kelsey

Institution

Duke University

brain tumor research

mesothelioma

Russell Hales

Institution

Johns Hopkins University

radiation oncology

oncology

Graham W. Warren, M.D., Ph.D

Institution

Medical University of South Carolina

oncology

cancer care

Timothy Showalter

Institution

University of Virginia

radiation oncology

oncology

Amar U. Kishan

Institution

University of California, Los Angeles

radiation oncology

clinical outcomes research

Maria Werner-Wasik

Institution

Thomas Jefferson University

clinical radiation oncology

radiation oncology

Matthew Schipper

Institution

University of Michigan

radiation oncology

oncology

Billy Loo

Institution

Stanford University

radiation oncology

oncology

Clifford G. Robinson

Institution

Washington University in St. Louis

radiation

radiation oncology